Ileana L. Piña discusses the unequivocal findings of the PARADIGM-HF study of a new combination angiotensin receptor-neprilysin inhibitor and its future in HFpEF.
Ileana L. Piña discusses the unequivocal findings of the PARADIGM-HF study of a new combination angiotensin receptor-neprilysin inhibitor and its future in HFpEF.